Hepatic and adrenal cholesterol biosynthesis were investigated in the human fetus in vitro by measuring the incorporation of acetate-2-14C into cholesterol by slices of liver and adrenals from the same fetus. To differentiate neutral lipids from cholesterol biosynthesis, the radioactivity was measured in the nonsaponifiable neutral lipid fraction and in cholesterol isolated and purified as its crystalline 5,6-dibromo-derivative.
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We have previously shown that cholesterol, perfused to the midterm (2) and term (3) human placenta in situ can be utilized in the synthesis of neutral steroids.
Recently, Hellig et al (4) have demonstrated that circulating cholesterol (primarily of maternal origin) is utilized for most if not all of placental progesterone biosynthesis in pregnancies marked by anencephalic fetuses. However, the de novo synthesis of cholesterol by the placenta is minimal at best (5). In contrast, we and others have shown that the human midterm fetal testis has the capacity for de novo synthesis of free steroids;
whereas, the fetal adrenal synthesizes both free and conjugated steroids (6-8). It seemed of interest to report our studies on the relative capacities of the human fetal adrenal and liver to synthesize cholesterol. Studies were also performed to assess indirectly whether 7-dehydrocholesterol is an obligatory intermediate in the biosynthesis of cholesterol in these organs.
MATERIALS AND METHODS
Human male fetal livers and adrenals were obtained following hysterotomy for therapeutic termination of pregnancy.
The adrenals and livers were freed of extraneous tissue, blotted, and slices prepared within 15 min. of operation with a Stadie-Riggs microtome. Both adrenal and liver slices were preincubated (30 min.) and incubated (3 hr.) in Krebs-Ringer bicarbonate buffer (with added glucose), based on earlier studies on cholesterogenesis in bovine adrenals (9). Cholesterol was isolated (9) by the addition of I00 mg carrier, brominated (i0,ii) and the resulting 5,6-dibromocholestan-3~-ol recrystallized (4 times from ethyl acetate-methanol) to radiochemical purity.
To assess whether 7-dehydrocholesterol is an obligatory intermediate in cholesterol biosynthesis in these organs, identical studies, from the same fetal specimens, were carried out in the presence of trans-l,4-bis (2-chlorobenzylaminomethyl) cyclohexane dihydrochloride (AY-9944), ixl0-4M final concentration.
RESULTS
The extent of cholesterol biosynthesis from acetate in the human fetal adrenal and liver and the almost total inhibition of this conversion by AY-9944 are shown in Table i was incorporated into tissue cholesterol. Kritchevsky et al (12) have reported up to 2% acetate-l-14C was incorporated into cholesterol by rat liver slices.
In fetal adrenal slices, Bloch and Benirschke (8) demonstrated the capacity to biosynthesize steroids from acetate-l-14C
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with cholesterol as the probable intermediate. However, in their study, the cholesterol was isolated by digitonin precipitation, a method that has been shown to be non-specific for cholesterol (i0).
In vivo, Davis et al (13) It should be noted that the total radioactivity in the neutral lipid fraction was much less affected by AY-9944 than the cholesterol fraction. This latter finding may be explained by previous in vitro (16,17) and in vivo (18-20) studies in the rat that showed that AY-9944 inhibits the conversion of 7-dehydrocholesterol to cholesterol. The 7-dehydrocholesterol accumulates, is present in the neutral lipid fraction, but is separated from cholesterol when the latter is converted to 5,6-dibromocholesterol and recrystallized to radiochemical purity (18).
In %he newborn (3j21), the total seru~ cholesterol (67 mg ~ 4 mg/100 ml) is lower than the maternal serum (222 ~ 9 mg/ i00 ml). A low level of circulating blood cholesterol in the fetus might explain a high rate of fetal liver cholesterogenesis, i.e., the absence of a negative feedback inhibition by cholesterol. In the adult, dietary cholesterol apparently provides no feedback control over cholesterol synthesis (22) .
